CorMatrix Cardiovascular (Marietta, Georgia) reported that the FDA has granted the company full IDE approval for its ongoing multi-center, prospective, randomized clinical trial aiming to demonstrate the safety and efficacy of the CorMatrix ECM for pericardial closure to reduce the incidence of new onset postoperative atrial fibrillation following isolated primary coronary artery bypass graft (CABG) surgery.

As most of the U.S. population prepares for the rapidly-approaching Thanksgiving holiday, I will be visiting our neighbor to the north, feasting my eyes on all that Ontario has to offer in the way of advanced medical devices. Medical Device Daily has been invited by the Ontario Ministry of Economic Development and Innovation (MEDI) to participate in a medical device media tour of the Canadian province. Throughout my visit, I plan to post frequent blogs here about my experience on the tour and what I learn about Ontario’s medical device industry. I also plan...